AGC patients showing progression after S-@ monotherapy for advanced cancer or recurrence within @ months after completion of S-@ adjuvant therapy were randomly allocated to CPT-@ / CDDP ( CPT-@ , @ mg/m ( @ ) ; CDDP , @ mg/m ( @ ) , q@w ) or CPT-@ ( @ mg/m ( @ ) , q@w ) .